The expression of cancerous inhibitor of protein phosphatase 2A (CIP2A) has been reported to activate Akt and inhibit caspase-3, caspase-9, and PARP for promoting the anti-apoptotic effect of RA associated FLS (34). The gene discussed is CASP9; the disease is rheumatoid arthritis.